Sarissa Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $6.76M | Hold |
|
|||||
|
2024
Q1 | $5.56M | Buy |
|
|||||
|
2023
Q4 | $5.99M | Buy |
|
|||||
|
2023
Q3 | $5.49M | Hold |
|
|||||
|
2023
Q2 | $5.46M | Hold |
|
|||||
|
2023
Q1 | $6.46M | Sell |
|
|||||
|
2022
Q4 | $11.3M | Sell |
|
|||||
|
2022
Q3 | $17.5M | Hold |
|
|||||
|
2022
Q2 | $14.7M | Hold |
|
|||||
|
2022
Q1 | $22.6M | Sell |
|
|||||
|
2021
Q4 | $55.9M | Buy |
|
|||||
|
2021
Q3 | $56.4M | Sell |
|
|||||
|
2021
Q2 | $67.4M | Sell |
|
|||||
|
2021
Q1 | $77.7M | Sell |
|
|||||
|
2020
Q4 | $60.9M | Buy |
|
|||||
|
2020
Q3 | $16.7M | Buy |
|
|||||
|
2020
Q2 | $5.12M | Buy |
|